BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11586443)

  • 21. Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China.
    Li Y; Yu DB; Li YS; Luo XS; Liang YS; Bartley PB; McManus DP
    Trans R Soc Trop Med Hyg; 2002; 96(2):210-5. PubMed ID: 12055818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratorial evaluation of urinary schistosomiasis in Brazilians after staying in Mozambique.
    da Silva IM; Tsang V; Noh J; Rey L; Conceição MJ
    Rev Soc Bras Med Trop; 2006; 39(3):272-4. PubMed ID: 16906252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
    Grogan JL; Kremsner PG; van Dam GJ; Metzger W; Mordmüller B; Deelder AM; Yazdanbakhsh M
    J Infect Dis; 1996 May; 173(5):1242-7. PubMed ID: 8627078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment.
    Kihara JH; Njagi EN; Kenya EU; Mwanje MT; Odek AE; van Dam G; Kahama AI; Ouma JH
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1024-30. PubMed ID: 19647844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
    Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
    J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of Egg Excretion of
    Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
    Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium.
    Mutapi F; Roussilhon C; Mduluza T; Druilhe P
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):405-9. PubMed ID: 17568947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.
    Mutapi F; Mduluza T; Gomez-Escobar N; Gregory WF; Fernandez C; Midzi N; Maizels RM
    BMC Infect Dis; 2006 Jun; 6():96. PubMed ID: 16764709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
    Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
    Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.
    Honkpehedji YJ; Adegnika AA; Dejon-Agobe JC; Zinsou JF; Mba RB; Gerstenberg J; Rakotozandrindrainy R; Rakotoarivelo RA; Rasamoelina T; Sicuri E; Schwarz NG; Corstjens PLAM; Hoekstra PT; van Dam GJ; Kreidenweiss A;
    BMC Infect Dis; 2020 Sep; 20(1):718. PubMed ID: 32993559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
    Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
    J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of indirect diagnostic tests for Schistosoma haematobium infection after repeated rounds of mass treatment with praziquantel in Mpwapwa and Chakechake districts in Tanzania.
    Ngasala B; Juma H; Mwaiswelo RO
    Int J Infect Dis; 2020 Jan; 90():132-137. PubMed ID: 31693938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
    King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
    Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics in Morbidity Markers and Cytological Observations Made in Urine of
    Tetteh-Quarcoo PB; Ampong A; Dayie NTKD; Ahenkorah J; Udofia EA; Afutu E; Aryee R; Niriwa BP; Kotey FCN; Donkor ES; Ayeh-Kumi PF
    Med Sci (Basel); 2022 Feb; 10(1):. PubMed ID: 35225947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
    Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
    J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
    Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
    Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
    Wilson S; Jones FM; Fofana HK; Doucouré A; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
    PLoS Negl Trop Dis; 2013; 7(3):e2149. PubMed ID: 23556029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.
    Mutapi F; Ndhlovu PD; Hagan P; Woolhouse ME
    Parasite Immunol; 1997 Jun; 19(6):255-63. PubMed ID: 9364555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.